Psyence Biomedical (PBM) Payables (2022 - 2026)

Psyence Biomedical has reported Payables for 5 years, with the latest figure at $407714.0 in Q1 2026.

• On a quarterly basis, Payables rose 3.41% year-over-year to $407714.0 in Q1 2026; TTM through Mar 2026 was $407714.0, a 3.41% increase from a year earlier, with the FY2026 full-year figure at $407714.0, up 3.41% from the prior year.
• Payables was $407714.0 for Q1 2026 at Psyence Biomedical, down from $644700.0 in the prior quarter.
• The five-year high for Payables was $2.1 million in Q3 2024, with the low at $394270.0 in Q1 2025.
• Average Payables over 5 years is $1.1 million, with a median of $1.0 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Payables surged 50.84% in 2024, then slumped 78.08% in 2025.
• Over 5 years, Payables stood at $417712.0 in 2022, then surged by 235.11% to $1.4 million in 2023, then soared by 50.84% to $2.1 million in 2024, then tumbled by 69.47% to $644700.0 in 2025, then plunged by 36.76% to $407714.0 in 2026.
• The last three Payables figures came in at $407714.0 (Q1 2026), $644700.0 (Q3 2025), and $394270.0 (Q1 2025), per Business Quant data.